Longitudinal analysis of the effect of apolipoprotein E varepsilon4 and education on cognitive performance in elderly subjects: the PAQUID study
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The apolipoprotein E (apoE) epsilon4 allele has been shown to be a risk factor for dementia, but it is not clear to what extent apoE affects overall cognitive function in non-demented elderly subjects, or how this risk may be modified by gene-environment interactions. OBJECTIVE: To examine changes in cognitive function in elderly people as a function of the apoE epsilon4 phenotype. METHODS: A community based prospective cohort study of 600 non-demented subjects aged over 65 years living in Gironde (France) was analysed to evaluate change over time (seven years) in scores on the mini-mental state examination (MMSE). RESULTS: Age at cohort inception was negatively associated with cognitive performance for both epsilon4 carriers and non-carriers (p < 0.001). The evolution of MMSE scores differed as a function of age: scores remained stable among younger subjects but decreased over time in older subjects. The epsilon4 allele was shown to be significantly associated with lower cognitive performance at baseline (p = 0.02). The course of cognitive performance during the follow up was the same for both epsilon4 carriers and non-carriers. Lower educational level was associated with lower cognitive performance at baseline (p < 0.001) and the effect of an epsilon4 allele on cognitive performance disappeared after adjustment for education. When incident cases of dementia were excluded, the results were unchanged except for the course of the MMSE scores, which now remained stable over time in the older subjects. CONCLUSIONS: apoE epsilon4 carriers show decreased MMSE scores compared with epsilon4 non-carriers, but the effect of apoE on cognition disappears after adjustment for education. Non-demented elderly people maintain a stable cognitive performance regardless of their apoE phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Apolipoprotein E polymorphism and Alzheimer's disease
Poirier, J., Bertrand, P., Poirier, J., Kogan, S., Gauthier, S., Poirier, J., Gauthier, S., Davignon, J., Bouthillier, D., & Davignon, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)91705-q · Cited by 1,108
Protection against Alzheimer's disease with apoE ∈2
Talbot, C., Lendon, C., Craddock, N., Shears, S., Morris, J., & Goate, A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92557-7 · Cited by 225
Farrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124
Unger, J. M., van Belle, G., & Heyman, A. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb02570.x · Cited by 58
Cited by
Plassman, B. L., Williams, J. W., Burke, J. R., Holsinger, T., & Benjamin, S. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-3-201008030-00258 · Cited by 681
Environmental Influences on Cognitive and Brain Plasticity During Aging
Kramer, A. F., Bherer, L., Colcombe, S. J., Dong, W., & Greenough, W. T. (2004) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/59.9.m940 · Cited by 503
“A recent report of the PAQUID (Personnes [people] Agéed [aged] QUID [Latin: ‘‘about what’’) research programwith a sample of 547 French seniors aged 65–94 years suggests that education is associated with better MMSE scores at baseline but does not predict decline over a 1 to 10 year period (52) [see also (53,54)].”
BackgroundApolipoprotein E and Cognitive Performance: A Meta-Analysis.
Small, B. J., Rosnick, C. B., Fratiglioni, L., & Bäckman, L. (2004) · Psychology and Aging · doi:10.1037/0882-7974.19.4.592 · Cited by 447
Brain reserve and cognitive decline: a non-parametric systematic review
VALENZUELA, M. J., & SACHDEV, P. (2006) · Psychological Medicine · doi:10.1017/s0033291706007744 · Cited by 373
Educational attainment and cognitive decline in old age
Wilson, R. S., Hebert, L. E., Scherr, P. A., Barnes, L. L., Mendes de Leon, C. F., & Evans, D. A. (2009) · Neurology · doi:10.1212/01.wnl.0000341782.71418.6c · Cited by 354
The NIH Cognitive and Emotional Health Project: Report of the Critical Evaluation Study Committee
Hendrie, H. C., Albert, M. S., Butters, M. A., Gao, S., Knopman, D. S., Launer, L. J., Yaffe, K., Cuthbert, B. N., Edwards, E., & Wagster, M. V. (2006) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2005.11.004 · Cited by 323
Education and cognitive reserve in old age
Wilson, R. S., Yu, L., Lamar, M., Schneider, J. A., Boyle, P. A., & Bennett, D. A. (2019) · Neurology · doi:10.1212/wnl.0000000000007036 · Cited by 282
Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease
TWAMLEY, E. W., ROPACKI, S. A. L., & BONDI, M. W. (2006) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617706060863 · Cited by 273
Education and Cognitive Decline in Older Americans: Results From the AHEAD Sample
Alley, D., Suthers, K., & Crimmins, E. (2007) · Research on Aging · doi:10.1177/0164027506294245 · Cited by 269
Early-Life Risk Factors for Alzheimer Disease
Borenstein, A. R., Copenhaver, C. I., & Mortimer, J. A. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000201854.62116.d7 · Cited by 257
Neuroprotective effects of cognitive enrichment
Milgram, N. W., Siwak-Tapp, C. T., Araujo, J., & Head, E. (2006) · Ageing Research Reviews · doi:10.1016/j.arr.2006.04.004 · Cited by 146
Beydoun, M. A., Boueiz, A., Abougergi, M. S., Kitner-Triolo, M. H., Beydoun, H. A., Resnick, S. M., O'Brien, R., & Zonderman, A. B. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.017 · Cited by 139
“…participants at first visit), their case-control or cross-sectional designs, or short follow-up periods (Ͻ10 years), a large portion of null studies (Riley et al., 2000; Small et al., 2000; Smith et al., 1998; Winnock et al., 2002; Yip et al., 2002) have evaluated only overall cognitive status.”
BackgroundInfluentialA nonlinear model with latent process for cognitive evolution using multivariate longitudinal data
Proust, C., Jacqmin‐Gadda, H., Taylor, J. M. G., Ganiayre, J., & Commenges, D. (2006) · Biometrics · doi:10.1111/j.1541-0420.2006.00573.x · Cited by 107
“Indeed, the presence of one or two 4 alleles of apoE is associated with a higher risk of Alzheimer’s disease (Farrer et al., 1997) but it is not well established whether the 4 allele is more generally associated with cognitive ageing (Winnock et al., 2002).”
BackgroundDore, G. A., Elias, M. F., Robbins, M. A., Elias, P. K., & Nagy, Z. (2009) · Diabetologia · doi:10.1007/s00125-009-1497-2 · Cited by 81
CSF Apo-E levels associate with cognitive decline and MRI changes
Initiative, F. T. A. D. N., Toledo, J. B., Da, X., Weiner, M. W., Wolk, D. A., Xie, S. X., Arnold, S. E., Davatzikos, C., Shaw, L. M., & Trojanowski, J. Q. (2014) · Acta Neuropathologica · doi:10.1007/s00401-013-1236-0 · Cited by 71
Sex Difference in the Association of APOE4 with Memory Decline in Mild Cognitive Impairment
Wang, X., Zhou, W., Ye, T., Lin, X., Zhang, J., & Initiative, F. A. D. N. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-181234 · Cited by 51
Metadata
- Authors
- Winnock, M.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2002-06-01
- Volume
- 72
- Issue
- 6
- Pages
- 794-797
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2068353776
- Cited by
- 81
- References
- 5
- FWCI
- 3.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.